Training the next generation of investigators has long been a priority at Children’s Hospital of Philadelphia. There are numerous opportunities throughout the year to celebrate the accomplishments of our trainees and honor their commitment to science.
Category Archive: Genetics
A common adage in medical training goes, “When you hear hoofbeats, think horses (not zebras).” For most doctors in conventional practice, that means that exotic explanations are rarely right. The most prosaic diagnosis for a patient’s symptoms is usually the correct one.
Whether children are under the steady hand of surgeon and anesthesiologist, or medical and research trainees are under the guidance of an experienced mentor, knowledge makes all the difference. This much is clear from the top stories in our weekly roundup of research news at The Children’s Hospital of Philadelphia.
When something important is missing, we often search for a replacement. After many years of looking, a team of researchers at The Children’s Hospital of Philadelphia and the University of Missouri have found a way to substitute for a missing gene linked to a relentless childhood neurodegenerative disease.
Advances in genomic sequencing hold enormous opportunities for more precise diagnosis of pediatric cancer and then targeting therapies toward the genetic alterations that are driving individuals’ disease.
A recent Forbes article on the resurrection of the gene therapy business featured The Children’s Hospital of Philadelphia gene therapy expert Katherine A. High, MD.
Traditionally, genetic counselors interview parents and hand-draw pedigrees, but they now have a new app to create those diagrams digitally on an iPad® screen with a few finger taps.
For her pioneering hemophilia and gene therapy research, Children’s Hospital hematologist Katherine A. High, MD, director of the Center for Cellular and Molecular Therapeutics (CCMT), was recently honored with the 2013 E. Donnall Thomas Lecture and Prize at the American Society of Hematology (ASH) Annual Meeting.
A report on American Public Media’s Marketplace on DNA sequencing and its effect on (and creation of) personalized medicine — “the next big thing in health care” — featured input from CHOP’s Nancy B. Spinner, PhD.
Please vote for CHOP scientists Ian Krantz and Nancy Spinner, who are in the running for the Time 100--Time Magazine’s annual list of influential people from around the world.